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Lipopolysaccharide is a major glycolipid component in the outer leaflet of the outer membrane (OM), a peculiar permeability
barrier of Gram-negative bacteria that prevents many toxic compounds from entering the cell. Lipopolysaccharide transport
(Lpt) across the periplasmic space and its assembly at the Escherichia coli cell surface are carried out by a transenvelope complex
of seven essential Lpt proteins spanning the inner membrane (LptBCFG), the periplasm (LptA), and the OM (LptDE), which ap-
pears to operate as a unique machinery. LptC is an essential inner membrane-anchored protein with a large periplasm-protrud-
ing domain. LptC binds the inner membrane LptBFG ABC transporter and interacts with the periplasmic protein LptA. How-
ever, its role in lipopolysaccharide transport is unclear. Here we show that LptC lacking the transmembrane region is viable and
can bind the LptBFG inner membrane complex; thus, the essential LptC functions are located in the periplasmic domain. In ad-
dition, we characterize two previously described inactive single mutations at two conserved glycines (G56V and G153R, respec-
tively) of the LptC periplasmic domain, showing that neither mutant is able to assemble the transenvelope machinery. However,
while LptCG56V failed to copurify any Lpt component, LptCG153R was able to interact with the inner membrane protein com-
plex LptBFG. Overall, our data further support the model whereby the bridge connecting the inner and outer membranes would
be based on the conserved structurally homologous jellyroll domain shared by five out of the seven Lpt components.
Lipopolysaccharide (LPS) is a unique glycolipid present in theouter layer of the outer membrane (OM) of Gram-negative
bacteria (1, 2). The presence of LPS in the outer leaflet of the OM
largely contributes to the permeability barrier properties exhib-
ited by this peculiar membrane and enables Gram-negative bac-
teria to survive in harsh environments and to exclude several an-
tibiotics effective against Gram-positive organisms (3). LPS
biogenesis is a complex process: it involves synthesis of the differ-
ent moieties at the inner leaflet of the inner membrane (IM),
translocation across the IM, transport across the aqueous
periplasmic space, and insertion at the outer leaflet of theOM.The
LPS biosynthetic pathway is well understood (1); much less
known is the mechanism by which such a large amphipathic mol-
ecule is transported across the periplasm to its final destination,
the cell surface. Seven essential lipopolysaccharide transport pro-
teins (LptABCDEFG) are required for LPS transport. They are
located in three distinct cellular compartments of the Escherichia
coli cell envelope, IM, periplasm, and OM and assemble in a tran-
senvelope complex that bridges the IM and OM (4). The IM
LptBFG complex builds an ABC transporter that provides the en-
ergy for LPS transport (5). LptF and LptG are the transmembrane
(TM) components (6), whereas LptB is the IM-associated ATP
binding protein (5). LptC is a small bitopic protein hosting a single
TM region and a large periplasmic domain (7). LptC binds to the
IM protein complex, although its association does not affect the
ATPase activity of the LptBFG complex (5). At theOM, the-bar-
rel LptD protein and the lipoprotein LptE build up a complex
responsible for LPS translocation across the OM in the final stages
of assembly (8–10). LptA, the periplasmic component of the ma-
chinery (11), bridges the IM and OM interacting with LptC (12)
and with the N-terminal domain of LptD (13). LptA and LptC
display remarkably similar jellyroll folds despite the lack of any
sequence similarity (7, 14). Interestingly, structure predictions of
the LptD N-terminal periplasmic domain suggest a fold very sim-
ilar to that of LptA and LptC, indicating that the bridge between
the IM and OM may be built through interaction of structurally
related domains (13) which are also similarly predicted for the
periplasmic regions of LptF and LptG (http://zhanglab.ccmb.med
.umich.edu/I-TASSER/) (12).
Coordination of Lpt protein assembly with LPS transport is
crucial to prevent LPSmistargeting. Indeed, the sevenLpt proteins
function in a highly concerted manner and depletion of any of
them causes accumulation of the LPS at the periplasmic face of the
IM (6, 11). Moreover, assembly of the Lpt bridge between the IM
and OM requires formation of correct disulfide bonds in LptD
(13), which in turn depends on the correct assembly of the LptDE
complex (15).
We previously isolated and partially characterized two inactive
lptC mutant alleles carrying mutations at two conserved glycines
(G56 and G153) of the protein. Our results suggested that the
C-terminal region of LptC is implicated in LptA binding and that
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misassembly of the Lpt components at either the IM or the OM
results in LptA degradation (12). We present here a further char-
acterization of suchmutant proteins with regard to their effects on
assembly of the Lpt transport complex. We find that LptCG153R
interacts only with the IM LptBFG complex, whereas LptCG56V
fails to interactwith any of the Lpt components. Bymeans ofX-ray
crystallography (the LptCG153R three-dimensional structure,
here presented at 2.8-Å resolution), we establish that the G153R
mutation does not induce significant structural perturbations, in-
dicating that the observed inhibitory effects are not the result of
evident conformational changes. Moreover, we show that the TM
region of LptC is dispensable and not required for interactionwith
the IM LptBFG complex, further supporting the model whereby
the bridge connecting IM and OMwould be based on the interac-
tion between the conserved structurally homologous jellyroll do-
mains shared by five (LptACDFG) out of the seven Lpt compo-
nents.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plas-
mids are listed in Table 1. Bacteria were grown in LDmedium (16).When
required, 0.2% (wt/vol) L-arabinose (as an inducer of the araBp pro-
moter), 0.1mM IPTG (isopropyl--D-thiogalactopyranoside), 100g/ml
ampicillin, 25 g/ml chloramphenicol, 25 g/ml kanamycin, 2.5 g/ml
rifampin, 50 g/ml bacitracin, 10 g/ml novobiocin, 0.5% (wt/vol) SDS
(sodium dodecyl sulfate), and 1.0 mM EDTA were added. Solid media
were prepared as described above with 1% (wt/vol) agar. The AMM04
strain (Table 1) was created by P1 transduction transferring the lptD-
SPA::Kan cassette from C-terminal LptD-SPA (sequential peptide affin-
ity) (17) in AM604 (MC4100 ara) (18).
Plasmid construction. Plasmids used in this study are listed in Table
1. The oligonucleotides used are listed in Table 2. Plasmids pGS112 and
pGS114 express MalFTMLptC-H and MalESSLptC-H versions of LptC,
respectively, from the IPTG-inducible ptac promoter. MalFTMLptC-H is
composed of the first MalF transmembrane region (TM; amino acids 1 to
36) (19) fused to the periplasmic portion of LptC, starting at amino acid
24. MalESSLptC-H is composed of the 26-amino-acid-long signal se-
quence (SS) of MalE (20) fused to LptC starting at amino acid 24. The
malFTM lptC-H and malESS lptC-H chimeric genes were obtained by
three-step PCR (21) using theMG1655 chromosome as the template. The
final PCR products were EcoRI-HindIII digested and cloned in pGS100
cut with the same enzymes. EcoRI-HindIII inserts in pGS112 and pGS114
were verified by sequencing. Plasmids pET23/42-LptCG56V and pET23/
42-LptCG153R, expressing LptCG56V andLptCG153Rwith aC-terminal
His8 tag from the T7 promoter, were constructed by using a QuikChange
site-directedmutagenesis kit (Stratagene) with pET23/42LptC as the tem-
plate and with primers listed in Table 2, as previously described (12).
Plasmids pET23/42-MalFTMLptC and pET23/42-MalESSLptC expressing
MalFTMLptC and MalESSLptC with a C-terminal His8 tag from the T7
promoter were constructed by cloning into NdeI-XhoI-digested
pET23/42 fragments obtained by PCR using pGS112 and pGS114 plas-
mids as the template and digested with the same enzymes. NdeI-XhoI
insertions in pET23/42-MalFTMLptC and pET23/42-MalESSLptC were
verified by sequencing. Plasmid pQEsH-lptCG153R expressing His6-
LptC24–191G153R from the T5 promoter was constructed as described
above using plasmid pQEsH-lptC (12) as the template. The periplasmic
region of LptF (residues 128 to 252) was amplified using primers AP217
TABLE 1 Bacterial strains and plasmids
Bacterial strain or plasmid Characteristic(s)a Reference or source
Bacterial strains
AM604 MC4100 ara 18
AMM04 AM604 lptD-SPA::Kan This study
M15/pREP4 F lac thi mtl/pREP4 Qiagen
BL21 F dcm ompT hsdS(rB
mB
) gal  (DE3) Stratagene
DH5 (argF-lac169) 80dlacZ58(M15) glnV44(AS)  rfbD1 gyrA96 recA1
endA1 spoT1 thi-1 hsdR17
41
FL905 AM604(kan araC araBp-lptC)1 11
C-terminal LptD-SPA DY330 lptD-SPA::Kan 17
NR698 MC4100 imp4213 40
Plasmids
pET23/42 pET23a() with multiple cloning sites of pET42a(), T7 promoter; Apr 18
pET23/42-LptC pET23/42-lptC-H 4
pET23/42-LptCG56V pET23/42-lptCG56V-H This study
pET23/42-LptCG153R pET23/42-lptCG153R-H This study
pET23/42-MalESSLptC pET23/42-malESSlptC1–23-H This study
pET23/42-MalFTMLptC pET23/42-malFTMlptC1–23-H This study
pET29 pET29b(), T7 promoter; Kanr Novagen
pET29-LptF128–252 pET29b-lptF128–252-H This study
pQE30 T5 promoter Qiagen
pQEsH-lptC pQE30 sH-lptC24–191 12
pQEsH-lptCG56V pQE30 sH-lptC24–191G56V This study
pQEsH-lptCG153R pQE30 sH-lptC24–191G153R This study
pGS100 pGZ119EH derivative, contains TIR sequence downstream of ptac; Cmr 36
pGS108 pGS100 ptac-lptC-H 36
pGS108G56V pGS100 ptac-lptCG56V-H 12
pGS108G153R pGS100 ptac-lptCG153R-H 12
pGS112 pGS100 ptac-malFTMlptC 1–23-H This study
pGS114 pGS100 ptac-malESSlptC 1–23-H This study
a Antibiotic resistance to ampicillin, chloramphenicol, and kanamycin is indicated by Apr, Cmr, and Kanr, respectively.
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and AP218 (Table 2). The resulting fragment was digested with NdeI and
XhoI and ligated into pET29b (Novagen) cut with the same enzymes to
give plasmid pET29-LptF128–252.
Affinity purification and immunoprecipitation. AMM04 harboring
pET23/42, pET23/42-LptC, pET23/42LptCG56V, and pET23/42-
LptCG153R and AM604 harboring pET23/42-MalFTMLptC and pET23/
42-MalESSLptC were used in affinity purification and immunoprecipita-
tion experiments as previously described (4) with the exception that the
cells were lysed by a single cycle through aCell Disrupter (One ShotModel
by Constant Systems Ltd.) at a pressure of 22,000 lb/in2. Immunoprecipi-
tation protein sampleswere separated on a 12.5%SDS-PAGEgel. Proteins
were fixed and stained with the Krypton infrared (IR) protein stain pro-
cedure (Thermo Scientific), and visualized by an Odyssey infrared imag-
ing system (LI-COR). The identity of LptB, LptF, and LptGwas confirmed
by mass spectrometry (MS). Samples from affinity purification were sep-
arated on a 10% SDS-PAGE gel, electroblotted, and immunodetected
using anti-Flag monoclonal antibody (Sigma-Aldrich) (1:2,000) to detect
LptD-SPA, anti-His monoclonal antibodies (Sigma-Aldrich) (1:3,000) to
detect wild-type and mutant LptC-H, and anti-LptA (1:2,000), anti-LptE
(1:5,000), anti-LptF (1:2,000), and anti-BamA (1:10,000) polyclonal an-
tibodies.
Cell fractionation. AM604 cells harboring pET23/42-LptC, pET23/
42-LptCG56V, pET23/42-LptCG153R, pET23/42-MalFTMLptC, and
pET23/42-MalESSLptC were grown overnight in LD medium. Periplas-
mic, cytoplasmic, and inner and outermembrane fractions were prepared
as described previously (22). Equal amounts of proteins from each frac-
tion were analyzed on a 12.5% SDS-PAGE gel. The proteins were detected
by immunoblotting using the anti-His monoclonal antibodies (Sigma-
Aldrich). The 55-kDa IM protein that is detected by anti-LptD antibodies
(11) and the OM protein BamA (18) were used as controls for confirma-
tion of good fractionation. Membrane fractionation was performed by
sucrose gradient ultracentrifugation according to published procedures
(4) with the following modifications. AMM04 cells harboring pET23/42-
LptC, pET23/42-LptCG56V, and pET23/42-LptCG153R were lysed by a
single cycle through a Cell Disrupter (One Shot Model by Constant Sys-
tems Ltd.) at 11,000 lb/in2. Aliquots from fractions were taken and diluted
with 6	 Laemmli buffer, and proteins were separated by SDS-PAGE fol-
lowed by immunoblot analysis to detect the LptD-SPA tag, the 55-kDa IM
protein, and LamB (1:5,000). Fraction remnants were trichloroacetic acid
(TCA) precipitated (4) and analyzed by immunoblotting using anti-His
monoclonal antibodies (Sigma-Aldrich) to detect wild-type and mutant
LptC-H.
Expression and purification of sH-LptC, sH-LptCG56V, sH-
LptCG153R, and LptF128–251-H. An overnight culture of M15/pREP4
expressing the periplasmic domain of wild-type and mutant LptC pro-
teins was diluted 1:100 in fresh medium and grown to the mid-logarith-
mic phase (optical density at 600 nm [OD600], 0.6) at 37°C. Expression of
sH-LptC, sH-LptCG56V, and sH-LptCG153R was induced by adding 0.5
mM IPTG, and incubation continued for 18 h at 20°C. Cells were then
harvested by centrifugation (5,000	 g, 10 min). The cell pellet was resus-
pended in buffer A (50mMNaH2PO4 [pH 8.0] containing 300mMNaCl,
10mM imidazole, and 10% glycerol), followed by 30min of incubation at
4°C with shaking in the presence of lysozyme (0.2 mg/ml), DNase (100
g/ml), 10mMMgCl2, and 1mMphenylmethylsulfonyl fluoride (PMSF;
Sigma-Aldrich). After disruption with one passage through a Cell Dis-
rupter (One Shot Model by Constant Systems Ltd.) at 25,000 lb/in2, un-
broken cells were removed by centrifugation (39,000 	 g, 30 min). The
soluble proteins were purified from the supernatant by using nickel-nitri-
lotriacetic acid (Ni-NTA) agarose (Qiagen). The columnwas washedwith
10 column volumes (CV) of 4% buffer B (50 mM NaH2PO4 [pH 8.0]
containing 300mMNaCl, 500mM imidazole, and 10%glycerol) in buffer
A. The protein was eluted by using a stepwise gradient obtained bymixing
buffer B with buffer A in 5 steps (10, 20, 50, 70, and 100% buffer B). At
each step, 1 CV was passed through the column. Eluate fractions were
analyzed on a 12.5% polyacrylamide SDS-PAGE gel. Pooled fractions
containing purified protein were dialyzed against 10 mM HEPES (pH
7.0)–50 mM NaCl for crystallization trials. Protein concentrations were
determined by using a Coomassie (Bradford) assay kit (Pierce) with bo-
vine serum albumin as the standard. For LptF128–252-H purification, a sta-
tionary-phase culture of BL21(DE3) cells harboring pET29-LptF128–252
(Table 1) was diluted 1:100 in freshmedium and grown to themid-logarith-
mic phase at 30°C. The expression of LptF128–252-H was induced with IPTG
TABLE 2 Oligonucleotides
Oligonucleotide
name Sequence (5=–3=)a Use and/or description
AP063 gtgatcacatctagatcagtggtggtggtggtggtgAGGCTGAGTTTGTTTGTTTTG LptC-H construction for pGS112 and pGS114; XbaI
AP204 cgagaggaattcATGGATGTCATTAAAAAGAAAC pGS112 construction with AP063; MalFTMLptC construction
by three-step PCR with AP205; EcoRI
AP205 GTATCGTCTTTTTCGGCCATTGCGTACATTAAAACAAC MalF-LptC hybrid primer for MalFTMLptC construction by
three-step PCR, with AP204
AP206 GTTGTTTTAATGTACGCAATGGCCGAAAAAGACGATAC MalF-LptC hybrid primer for pGS114 construction by three-
step PCR, with AP063
AP210 cgagaggaattcATGAAAATAAAAACAGGTGC pGS114 construction with AP063; MalESSLptC construction
by three-step PCR with AP211; EcoRI
AP211 GTATCGTCTTTTTCGGCCATGGCGAGAGCCGAGGCGGAAAAC MalE-LptC hybrid primer for pGS114 construction by three-
step PCR, with AP210
AP212 GTTTTCCGCCTCGGCTCTCGCCATGGCCGAAAAAGACGATAC MalE-LptC hybrid primer for pGS114 construction by three-
step PCR, with AP211
AP225 ggaattccatAtgAAAATAAAAACAGGTGCACGC pET23/42-MalFTMLptC construction with AP226; NdeI
AP226 ccgctcgagAGGCTGAGTTTGTTTGTTTTG pET23/42-MalFTMLptC and pET23/42-MalEssLptC
construction with AP225 and AP270; XhoI
AP270 ggaattccatAtgGATGTCATTAAAAAGAAACATTGGTGGC pET23/42-MalESSLptC construction with AP226; NdeI
AP164 GTCTATAACCCAGAAGTGGCACTAAGCTATCG pET23/42-LptCG56V and pQEsH-lptCG56V with AP165
AP165 CGATAGCTTAGTGCCACTTCTGGGTTATAGAC pET23/42-LptCG56V and pQEsH-lptCG56V with AP164
AP168 CTCGTCACGTTATACAGAACAACATTTAACTC pET23/42-LptCG153R and pQEsH-lptCG153R with AP168
AP169 GAGTTAAATGTTGTTCTGTATAACGTGACGAG pET23/42-LptCG153R and pQEsH- lptCG153R with AP169
AP217 gaattccatAtgGATGAAGTGTTAGCAGAAGCG pET29-LptF128–252 construction with AP218; NdeI
AP218 ccgctcgagGCGCATGTCCATCTGG pET29-LptF128–252 construction with AP217; XhoI
a Uppercase letters, E. coli genomic sequence; underlined lowercase letters, restriction sites; boldface letters, codons mutated by site-directed mutagenesis.
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as described above. Cell pellets were resuspended as described above and
disrupted with one passage through a Cell Disrupter (One Shot Model by
Constant Systems Ltd.) at 25,000 lb/in2, and unbroken cells were removed by
centrifugation (39,000	 g, 20min). LptF protein extraction andpurification
were then performed as described above excepting that the Ni-NTA agarose
(Qiagen) columnwas washed with 15 CV of 4% buffer B in buffer A. Pooled
fractions containing purified protein were dialyzed against phosphate-
buffered saline (PBS) buffer (137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4·2H2O, 2.0 mM KH2PO4, pH 7.4) and processed by the Primm
Company to obtain polyclonal antibodies against LptF raised in rabbit. The
resulting LptF antiserumwas used at a 1:2,000 dilution.
Crystal structureanalysis.Crystallization trials for sH-LptC24–191G153R
were set up in 96-well sitting drop plates (Greiner) using an Oryx 8.0
crystallization robot (Douglas Instruments), at a protein concentration of
22.3 mg/ml. Small (approximately 50-m-diameter) crystals grew after 1
week at 20°C in a 300-nl crystallization drop containing 50% protein and
50% reservoir solution (18% polyethylene glycol 5000monomethyl ether
[PEG-MME 5K], 0.1 M sodium acetate, pH 5.5) (Stura Footprint Screen
3.1, condition 18.2; Molecular Dimensions). Crystals were cryoprotected
with the same crystallization well solution supplemented with 30% glyc-
erol, prior to cryocooling in liquid nitrogen. The crystals belong to the
space group P212121, with two LptCG153R chains per asymmetric unit
(solvent content of 52.5%). Diffraction data were collected to 2.8-Å
resolution using synchrotron radiation (ID29 beamline; ESRF,
Grenoble, France) (Table 3). Raw data were processed and scaled with
XDS and Scala, respectively (23, 24). The three-dimensional structure of
LptCG153R was solved by molecular replacement using the structure of
the wild-type protein (Protein Data Bank [PDB] code 3MY2) as a search
model (7). The structure was refined using REFMAC5.4 (25) and fitted to
the generated electron densitymaps using Coot (26). All data were refined
to satisfactory final Rfactor and Rfree values and stereochemical parameters
(Table 3) (27, 28).
Protein structure accession number. The atomic coordinates and
structure factors for LptCG153R have been deposited with the Protein
Data Bank (http://www.rcsb.org) under PDB code 4B54.
RESULTS
Overexpression and subcellular localization of inactive LptC
mutant proteins. E. coli LptC is a conserved bitopic IM protein
with a single predictedN-terminal transmembrane helix (residues
W7 to M24) (Expasy, http://expasy.org/) and a large soluble
periplasmic domain (A25 to P191) (7). LptC interacts with the IM
protein complex LptBFGandwith LptA (5, 12) and bridges the IM
to the OM Lpt components via LptA (13).
We previously isolated two inactive lptC mutant alleles carry-
ing the single amino acid substitutions G56V and G153R, respec-
tively (12) (Fig. 1A). Growth of LptC depletion strain FL905
(Table 1) ectopically expressing LptCG56V is impaired under
nonpermissive conditions (absence of arabinose), whereas G153R
is a more severe mutation, as growth of LptC-depleted FL905
cells expressing LptCG153R is completely inhibited (12). More-
over, in vitro LptA binding by LptCG153R, but not by LptCG56V,
is impaired, thus implicating G153 in the interaction with LptA.
Both G56 and G153 are housed in two clusters of conserved resi-
dues in the periplasmic region of the protein (12). The two muta-
tions did not seem to affect in vivo LptC stability, as the abundance
of themutant proteins remained constant upon inhibition of pro-
tein synthesis (see Fig. S1 in the supplemental material), or to
modify the overall protein structure, as shown by circular dichr-
oism spectra (see Fig. S2 in the supplementalmaterial). Therefore,
the phenotypes of these two mutants may depend on the specific
role of the two LptC residues. To dissect their functional role, we
further analyzed the properties of the two mutants.
LptCG56V and LptCG153R were ectopically expressed in FL905,
and growth of cells was tested upon IPTG induction.Overexpression
of neither LptCG56V nor LptCG153R restored FL905 growth under
nonpermissive conditions (Fig. 1B,ara), suggesting that the defect
of LptC singlemutants is not due to a lower protein level. In linewith
previousobservations (12),LptCG153Roverexpression inhibitedcell
growth under permissive conditions (Fig. 1B,ara), suggesting that
the mutant protein is toxic for the cells.
To determine whether the G56V and G153R mutations could
lead to mistargeting of the corresponding mutant proteins, AM604
cells expressingLptCG56VorLptCG153Rmutantproteins fused to a
C-terminalHis8 tag were fractionated, and cytoplasmic, periplasmic,
IM, andOM fractions were analyzed by immunoblotting using anti-
His monoclonal antibodies. Both LptCG56V and LptCG153R cor-
rectly localized in the IM (Fig. 2).
Assembly of the Lpt export machinery in G56V and G153R
mutants.LptA, LptC, and theN-terminal region of LptDbuild the
transenvelope protein bridge that connects IM and OM, provid-
ing the route for LPS transport (13). To determine whether LptC
TABLE 3 Data collection and refinement parameters for LptCG153R
Parameter Value(s)
Data collection statistics
Space group P212121
Unit cell dimensions
a, b, c (Å) 48.9, 98.28, 123.56
 
  
  (°) 90
No. of unique reflections 12,846
Avg I/(I) 12.9 (3.2)a
Completeness (%) 99.5 (99.4)
Redundancya 5.1 (5.4)
Rmerge (%)
b 0.125 (0.722)
Refinement statistics
Resolution range (Å) 40.0–2.8
Rgen (%) 22.7
Rfree (%)
c 28.4
No. of molecules/a.u. 2
No. of atoms
Protein 2,043
Water 21
Acetate 1
Glycerol 1
B-factors (Å2)
Protein 57.1 (chain A), 68.5 (chain B)
Water 53.9
Acetate 76.3
Glycerol 62.8
RMSD
Bond lengths (Å) 0.005
Bond angles (°) 0.904
Ramachandran plot (%)
Favored 95.2
Allowed 100
a Values in parentheses represent the highest resolution shell (2.8 to 2.95 Å).
b Rmerge
 |I (I)/ I	 100, where I is the intensity of a reflection and (I) is the
average intensity.
c R-factor
 |Fo Fc|/|Fo|	 100. Rfree was calculated from 5% of randomly selected
data for cross-validation.
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mutant proteins are able to properly assemble the Lpt machinery,
we performed pulldown experiments according to the protocol
developed byChng and coworkers (4). Totalmembranes collected
fromAMM04 cells (producing a SPA-tagged LptD from the chro-
mosomally encoded lptD-SPA allele) ectopically expressing C-ter-
minally His-tagged LptC-H, LptCG56V-H, or LptCG153R-H
proteins from pET23/42 vector were solubilized and affinity puri-
fied. Samples were further processed either by immunoblotting
with a panel of specific antibodies (Fig. 3A) or by coimmunopre-
cipitation (Fig. 3B). TheOMprotein BamA, which is not enriched
in pulldown experiments with Lpt proteins (4), was used as a
loading control. As judged by the copurification profile of LptD,
LptE, and LptA, neithermutant appears to be able to interact with
the periplasmic component LptA and the OM complex LptD-
LptE (Fig. 3A). The faint LptD and LptE signals in both LptCG56V
and LptCG153R pulldown lanes appear to depend on nonspecific
binding to the resin, as they are visible in the empty vector control.
On the other hand, LptCG153R copurified LptF whereas
LptCG56V did not, thus indicating that the interaction with the
IM LptBFG complex was impaired by the LptCG56V but not by
the LptCG153Rmutation. This was confirmed by coimmunopre-
cipitation experiments (Fig. 3B), where the LptBFG protein bands
FIG 1 (A) Schematic representation of LptC and recombinant proteins. Proteins are drawn to scale, with the number of amino acids (aa) indicated on top.
Rectangles of lesser height indicate a region of non-LptC origin. Gray rectangles, signal sequence for export to periplasm; gray dotted rectangles, transmembrane
domain; white rectangles, LptC periplasmic domain; black rectangles, His tag; black dotted rectangle, MalE signal sequence. Arrows indicate positions of amino
acid substitution. (B) Overexpression of LptCG56V-H and LptCG153R-H mutant proteins in FL905 araBp-lptC conditional strain. Serial 10-fold dilutions of
FL905 cells transformedwith pGS100 (void), pGS108 (LptC-H), pGS108G56V (LptCG56V-H), or pGS108G153R (LptCG153R-H)were replicated on agar plates
supplemented with 0.2% arabinose (ara) or left unsupplemented (ara). The concentrations of IPTG used are indicated.
FIG 2 Subcellular localization of LptCG56V-H and LptCG153R-H mutant
proteins. Crude extracts (CE) and cytoplasmic (CY), inner membrane (IM),
periplasmic (PE), and outer membrane (OM) fractions from a AM604 wild-
type strain harboring pET23/42-LptC, pET23/42-LptCG56V, and pET23/42-
LptCG153R were prepared and analyzed byWestern blotting using monoclo-
nal -His. The IM 55-kDa protein and the OM BamA protein are used as IM
and OMmarkers, respectively.
FIG 3 LptCG56V-H and LptCG153R-H mutants fail to assemble a stable
transenvelope bridge. (A) Dodecyl--D-maltoside (DDM)-solubilized total
membranes from a wild-type AMM04 strain harboring pET23/42, pET23/42-
LptC, pET23/42-LptCG56V, and pET23/42-LptCG153Rwere affinity purified
using a Talon metal affinity resin. Proteins were then fractionated by SDS-
PAGE and immunoblotted with -LptE, -LptA, and -LptF, with -His to
detect LptC, and with -Flag to detect LptD-SPA. The OM BamA protein
binds to the Talonmetal affinity resin but is not enriched relative to the control
sample and was therefore used as loading control. (B) SDS-PAGE analysis of
samples (from affinity purification as described in panel A) immunoprecipi-
tated using -His. The identity of LptB, LptF, and LptG was confirmed byMS.
The band marked with the asterisk corresponds to the immunoglobulin light
chain.
Villa et al.
1104 jb.asm.org Journal of Bacteriology
were missing in the presence of the G56V mutant, but not of
G153R. Therefore, LptCG56V-H fails to interact with any Lpt
component, whereas LptCG153R-H can interact only with the IM
complex LptBFG. The pattern of LptCG153R interactions with
the Lpt components detected by the pulldown experiments de-
scribed above is consistent with the inability of thismutant to bind
LptA in vitro (12), in keeping with the observation that LptC in-
teraction with the OM components is mediated by LptA (13).
More intriguing was the phenotype of LptCG56V, which was pre-
viously shown to interact in vitrowith LptA (12) by copurification
experiments. In pulldown experiments, however, LptCG56V not
only did not coimmunoprecipitate the IM components, but also
did not copurify LptA and the OM LptDE complex. This discrep-
ancy may be explained by considering that in vivo copurification
experiments can also detect reassociation of unbound protein
partners (e.g., LptA-LptC), while pulldown experiments detect
only preassembled protein complexes.
Previous work demonstrated that wild-type LptC cofraction-
ates with both IM andOM in sucrose gradient ultracentrifugation
of E. colimembrane preparations (4). We therefore examined the
sedimentation profile of LptCG56V ectopically expressed in
AMM04 cells. While LptC-H cofractionated, as expected, with
both IM (fractions 6 to 10) and OM (fractions 18 to 22, also con-
taining LptD), LptCG56V was detected only in the IM fractions
(Fig. 4). Since LptCG56V does not seem to form a complex with
the IM LptBFG complex, its IM localization appears to depend on
its TM domain only. In addition, although LptCG56V is profi-
cient in LptA binding in vitro, it appears unable to associate in the
transenvelope LptC-LptA-LptD bridge.
Binding of LptC to IM protein complex LptBFG occurs via
the soluble periplasmic domain. To investigate the functional
role of the residues composing the predicted TM region, we con-
structed two LptC chimeric proteins in which the TM region was
replaced either by the 26-amino-acid-long signal sequence (SS 1
to 26) of MalE (MalESSLptC-H) (20) or by the first TM region
(TM 1 to 36) of the IM-spanning protein MalF (MalFTMLptC-H)
(19). In both constructs, the C-terminal region of LptC is fused to
a His8 tag (Table 1 and Fig. 1A).
To determine the subcellular localization of these LptC chime-
ras, periplasmic, cytoplasmic, IM, and OM fractions from the
wild-type AM604 strain ectopically expressing MalFTMLptC-H
and MalESSLptC-H from the T7 promoter at the basal level were
prepared and analyzed by immunoblotting using anti-His6-tag
monoclonal antibodies. MalFTMLptC-H localized in the IM frac-
tion, whereasMalESSLptC-Hwas detected only in the periplasmic
fraction, thus indicating that the MalE signal sequence promotes
the secretion of LptC lacking residues 1 to 23 of theTMregion into
the periplasmic space (Fig. 5A).
The chimeric malFTM lptC1–23 and malESS lptC1–23 genes
cloned into the pGS100 vector under the control of the IPTG-
inducible ptac promoter (plasmids pGS112 and pGS114, respec-
tively; Table 1) were tested for the ability to complement the lptC
conditional expression mutant FL905. Both MalFTMLptC-H and
MalESSLptC-H sustained FL905 growth under nonpermissive
conditions even when the chimeric proteins were expressed at the
basal level without IPTG (Fig. 6, LDara). To assess whether the
expression of the mutant proteins lacking the wild-type LptC TM
region affects OM integrity, we tested the sensitivity of FL905 cells
transformed with MalFTMLptC-H and MalESSLptC-H to several
toxic hydrophobic compounds (29, 30). As shown in Fig. 6, FL905
LptC depleted cells complemented by the LptC chimeras did not
show increased sensitivity to any of the tested antibiotics, indicat-
ing that the OM permeability barrier was intact.
The ability of LptC chimeras to recruit the IM LptBFG protein
complex was assessed by tandem affinity purification and immu-
noprecipitation using MalFTMLptC-H and MalESSLptC-H pro-
FIG 4 Sucrose gradient fractionation of AMM04 expressing LptC-H or
LptCG56V-H. Cultures of AMM04 harboring pET23/42-LptC and pET23/42-
LptCG56V were grown to an OD600 of 0.6. Crude extracts prepared as de-
scribed in Materials and Methods were fractionated by sucrose density gradi-
ent. Fractions were collected from the top of the gradient and immunoblotted
using antibodies recognizing the 55-kDa protein as an IMmarker and LamB as
an OM marker. -Flag and -His were used to detect LptD-SPA and LptC
His-tagged proteins, respectively.
FIG 5 Subcellular localization of MalFTMLptC-H and MalESSLptC-H chime-
ras and assembly to IM LptBFG subcomplex. (A) Crude extracts (CE) and
cytoplasmic (CY), inner membrane (IM), periplasmic (PE), and outer mem-
brane (OM) fractions from a AM604 wild-type strain harboring pET23/42-
MalFTMLptC and pET23/42-MalESSLptC were prepared and analyzed by
Western blotting using monoclonal -His. The IM 55-kDa protein and OM
BamA are used as IM and OM markers, respectively. (B) Total membranes
purified from a wild-type AM604 strain harboring pET23/42-MalFTMLptC
and pET23/42-MalESSLptC were affinity purified and analyzed by 10% SDS-
PAGE (upper part) and by Western blotting using anti-His and anti-LptF
antibodies (lower part).
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teins as baits. Both chimeras copurified the IM protein complex
LptBFG (Fig. 5B), suggesting that the Lpt proteinmachinery at the
IM is correctly assembled. These results suggest that the TM do-
main of LptC is not required for proper assembly and functional-
ity of the Lpt complex and that the periplasmic region of LptC is
sufficient to promote binding to the IM protein complex LptBFG.
Structure of the LptCG153R periplasmic domain. The three-
dimensional structure of the periplasmic region of E. coli LptC is
known and consists of 15 antiparallel -strands folded into a jel-
lyroll domain (7). The G153R amino acid substitution, a lethal
mutation that impairs interaction with LptA, is localized at the
terminus of-strand 12. To gain insights into the structural role of
the G153 residue, we determined the crystal structure of the
LptCG153R periplasmic domain (at 2.8-Å resolution), expressed
as a soluble cytoplasmic protein (residues 24 to 191) lacking the
transmembrane helix and with an N-terminal His6 affinity tag
(sH-LptCG153R) (Table 1).
sH-LptCG153R was found to be present as a dimer in the crys-
tallographic asymmetric unit, comprising two chains (A and B),
each organized into a twisted boat structure formed by the sand-
wiching of two -sheets (Fig. 7). The overall fold matches closely
that of the wild-type protein (C root mean square deviations
[RMSD] of 0.8 Å and 0.5 Å for chains A and B, respectively), with
electron density visible for residues 58 to 182 (chain A) and resi-
dues 59 to 184. In agreement with what has been reported for the
wild-type LptC domain structure (7), the N terminus is disor-
dered, the electron density being absent for the first 45 residues (9
belonging to the His tag region), and also for the last 7 C-terminal
residues.
As illustrated by the crystal structure, the R153 mutated resi-
due, located at the tip of -strand 12, projects inward, roughly
toward the axis of the elongated jellyroll, and is solvent accessible;
despite the introduction of a large positive side chain, the LptC
domain fold, which contributes to the Lpt bridge across the
periplasm, is unaltered, suggesting that the lack of activity of this
mutant is not related to alterations in the LptC global structure
(Fig. 7). Since glycine residues are often located in conformation-
ally flexible regions of the protein, it is possible that the G153R
substitution restricts the conformational changes that would be
required to allow interactions with other Lpt partners or the LPS
ligand.
DISCUSSION
LPS export across the periplasm to the cell surface requires seven
proteins (LptABCDEFG) that can copurify (4) and assemble into
a protein bridge connecting the IM to the OM (13). Based on
photo-cross-linking experiments, the architecture of the transen-
velope Lpt bridge has been established to consist of a head-to-tail
oligomeric assembly of the structurally homologous domains of
LptC and LptA and the N-terminal region of LptD (13). Accord-
ing to this architecture, LptA is the central component of the ma-
chinery, with its N-terminal region contacting the C-terminal re-
gion of LptC at the IM, and its C-terminal region linking the
N-terminal periplasmic region of LptD at the OM (13).
LptC is a bitopic IM protein with a single TM domain and a
large periplasmic region, whose structure has been recently re-
ported (7). LptC is essential for LPS transport, but its role in this
process is unclear. It stably associates to LptA (12) and to LptBFG
(5), although it does not affect the ATPase activity of this ABC
transporter (5). In this context, we set out to dissect the structure-
function relationships of LptC through the analysis of deletion
and point mutants.
Here we demonstrate that the TM region of LptC appears to be
dispensable for its function, as both a soluble periplasmic form of
FIG 6 Ectopically expressed LptC-H, MalFTMLptC-H, and MalESSLptC-H exhibit similar sensitivities to hydrophobic toxic compounds. Serial 10-fold dilutions of
stationary-phase culturesofFL905harboringpGS100(void),pGS108(LptC-H),pGS112(MalFTMLptC-H),orpGS114(MalESSLptC-H)were spottedontoLDmedium
with 25g/ml chloramphenicol or onto LDmediumwith 25g/ml chloramphenicol supplementedwith 0.5%SDSplus 1.0mMEDTA, 2.5g/ml rifampin, 50g/ml
bacitracin, and 10g/ml novobiocin in the presence (0.2% arabinose, ara) or absence ( ara) of arabinose. Strains AM604, AMM04, andNR698 (which has a small
in-frame deletion [imp4213] in the lptD gene conferring OMpermeability defects to hydrophobic toxic compounds [40]) were used as controls.
FIG 7 The crystal structure of LptCG153R. A secondary-structure cartoon rep-
resentation of the sH-LptCG153R dimer present in the crystal asymmetric unit is
shown.TheNandC termini ofmonomersA (green) andB (blue) are labeled, as is
the R153mutation (sticks). This figure was generated usingMac Pymol.
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LptC (MalESSLptC) and a chimera bearing the first TM region of
MalF (MalFTMLptC) are functional. Indeed, both chimeras com-
plement a conditional lptC mutant and copurify the IM LptBFG
protein complex. MalFTMLptC appears to bind the IM protein
complex more efficiently than the periplasmic MalESSLptC chi-
mera (Fig. 5B), suggesting that the TM region may facilitate the
interaction with LptFG. However, in LptC depleted cells ex-
pressing either chimeric protein, the permeability barrier of the
OM is unaffected. Therefore, LptC interaction with the IM
LptBFG subcomplex appears to bemediated only by the N-termi-
nal region of the periplasmic domain. This conclusion is further
supported by the fact that the defectivemutant protein LptCG56V
but not LptCG153R is unable to interact with LptBFG. LptCG56V
is unable to pull down LptA and theOMLptDE complex (Fig. 3A)
and does not colocalize with the OM in sucrose gradient fraction-
ation experiments (Fig. 4), although it is able to copurify LptA in
vitro (12). This is in line with the recently proposed architecture of
the LptCAD bridge that implicates the C-terminal region of LptC
in binding with the N-terminal region of LptA (13). The fact that
LptCG56V is not able to recruit LptA within the Lpt complex
might suggest that the impaired interaction with the IM LptBFG
proteins destabilizes the whole Lpt proteinmachinery that cannot
be copurified as a single complex. Alternatively, the assembly of
Lpt proteins may require an ordered/concerted process in which
LptC interaction with LptBFG would be necessary for LptA re-
cruitment. Therefore, formation of the transenvelope bridge
would be inhibited in the LptCG56V mutant to prevent LPS mis-
targeting.
Glycine 56 is located in the linker region that connects the LptC
TM segment to the periplasmic domain and is the first conserved
residue from the N terminus (7). Interestingly, G56 maps at the
end of one of the two disordered regions of the protein (residues
24 to 58) (7). It is not clear whether the structural effects of the
G56V point mutation affect the N-terminal disordered region of
the protein and/or extend to the C-terminal ordered structure
immediately adjacent to it. Interaction with LptFG may occur via
the unstructured linker region of LptC, in keeping with the idea
that natively unfolded or partly folded proteins fold into an or-
dered structure upon binding partner molecules/proteins (31).
Alternatively, the G56V mutation could interfere with the func-
tion of the C-terminal ordered structure immediately adjacent to
the 56 site. LptC andLptA share very similar structures (7, 14) and,
together with the N-terminal domain of LptD, belong to OstA
structural superfamily of proteins (32, 33). Three-dimensional
structure predictions reveal that the typical jellyroll fold of LptA
and LptC may be present in the terminal region of LptD (13) and
in the periplasmic loops of LptF and LptG (http://zhanglab.ccmb
.med.umich.edu/I-TASSER/) (12). It thus appears that this struc-
turally homologous domain, the “Lpt fold,” shared by every com-
ponent of the Lptmachinery, with the exception of LptB andLptE,
might be the common scaffold used to build the Lpt transenvelope
complex. LptA and LptC bind LPS in vitro (7, 34); therefore, the
“Lpt fold,” in addition to providing the structural element for
protein-protein interaction, may also establish a continuous path
across the periplasm for LPS transport from the IM to the OM.
The LptCG153R mutant displays reduced affinity for LptA in
vitro (12), being unable to pull downLptA and the LptDE complex
(Fig. 3A). G153 is a conserved residue, located at the end of
-strand 12 (7), in the proximity of the LptA-interacting residues
A172 andY182 located at the C-terminal edge (-strand 15) in the
LptC jellyroll (13). In this mutant, the small/apolar glycine 153 is
substituted with arginine, a positively charged residue with high
steric hindrance whose side chain faces inward toward the center
of the LptC jellyroll still being solvent exposed (Fig. 7). Neverthe-
less, themutant proteinmaintains the overall jellyroll architecture
and seems to be stable in vivo and in vitro (see Fig. S1 and S2 in the
supplemental material), despite the complete loss of LptC func-
tion linked to the G153R amino acid substitution; thus, the com-
plete loss of the function of this mutant might reflect a specific
role/interaction of the G153 residue. While G153 seems not to be
involved in LPS binding (35), our data do not suggest an obvious
explanation of how the G153R substitution impairs LptA interac-
tion. We can speculate that the G153R mutation impairs LptA
interaction by altering the electrostatics of the association inter-
face, or by preventing the attainment of a productive conforma-
tion through steric hindrance. Isolation of an external suppressor
of the lptCG153R mutant might help clarifying the structural basis
of the LptCG153R defect. LptCG153R, which binds LptBFG but
not LptA, is extremely toxic for cells, even when expressed in the
presence of a wild-type copy of LptC, whereas LptCG56V is not
(Fig. 1B); it is possible that LptCG153R titrates the LptBFG com-
plex, thus preventing the formation of the complete transenvelope
Lpt machine.
We previously found that LptA level decreases when the tran-
senvelope bridge is broken because of depletion of LptD and/or
LptE (12), suggesting that LptA is degraded when it is not bound
to the N-terminal region of LptD. Accordingly, it has been re-
cently demonstrated that the LptD-LptA interaction requires the
correct formation of at least one native disulfide bond in LptD
(15), which ultimately depends on a properly assembled LptD-
LptE translocon, as a regulatory mechanism to avoid LPS mistar-
geting (13). LptA is also degraded when LptC is missing, or in
LptC depleted cells expressing a truncated and highly unstable
LptC177–191 mutation, but not in LptC
 depleted cells expressing
LptCG153R or LptCG56V (12), despite both mutant proteins be-
ing unable to pull down LptA and LptDE (Fig. 3A). It is possible
that a properly folded LptC is required for LptA folding/matura-
tion/stability, thus explaining why LptA is stable in LptC de-
pleted cells complemented with LptCG56V and LptCG153R; in
fact, we have shown that the C-terminal region of LptCG56V is
proficient in LptA binding, while LptCG153R, despite being fully
inactive, maintains the jellyroll fold of the wild-type protein. The
strict functional interaction between LptC and LptA is reflected at
the genetic level, as the coding sequences of lptC and lptA overlap
by 32 nucleotides (36), suggesting a mechanism of translational
coupling to ensure LptA and LptC coordinated expression. Such
chromosomal organization is reminiscent of the type III secretion
system SicP unieffector chaperone and its cognate effector protein
SptP in Salmonella enterica serovar Typhimurium. Translation of
the SptP effector is coupled to that of its SicP chaperone, and this
prevents premature degradation of SptP and perhaps helps to tar-
get it for secretion (37). We (38) and others (34) found that over-
expression of LptA under slow-growth conditions results in
periplasmic localization of the protein. The accumulation of LptA
in the periplasm is detrimental for the cell, likely because of the
LptA tendency to oligomerize (39). Thus, LptC-LptA coexpres-
sion could be a regulative mechanism that ensures LptA associa-
tion to the Lpt transport system, avoiding its mistargeting.
Taken together, the data presented in this work indicate that
assembly of the Lptmachinery is finely regulated. The Lpt proteins
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exploit a conserved jellyroll folded domain to build the bridge
connecting IM and OM; therefore, achievement of a functional
Lptmachinery in the cellmust take place in a concertedmanner to
ensure that the component proteins recognize each other and as-
semble in a proper/ordered way.
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